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Three protein kinase C (PKC)-rl mutants were constructed in which the whole or part of the pseudosubstrate site was replaced with corresponding 
parts of the PKC-a pseudosubstrate site. The resulting chimaeric kinases were compared with wild-type PKC-r,~ in their ability to phosphorylate 
a PKC-q peptide substrate or histone. Changes in the pseudosubstrate site of PKC-rl are accompanied by changes in substrate selectivity, indicating 
that the substrate selectivity observed for PKC-r,r is at least in part due to its pseudosubstrate site. 
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1. INTRODUCTION 
Protein kinase C (PKC) is a serine/threonine kinase 
implicated in a variety of processes such as growth, 
differentiation, exocytosis and modulation of ion chan- 
nels and receptors [l-3]. Many PKC isotypes exist (in- 
dicated by the Greek symbols ~1, ~9, y etc.) which have 
a related structure but differ in amino acid composition 
[4-q. Each PKC isotype shows a different tissue distri- 
bution, responsiveness to extracellular signals and bio- 
chemical properties. Thus, it is conceived that the vari- 
ous PKC isotypes have separate functions in vivo. 
Previously, we reported that PKC-6, E and q are poor 
histone kinases in vitro, whereas PKC-a, p and y are 
known to be potent histone kinases [g-13]. This differ- 
ence is due to a difference in apparent affinity of the 
various PKC isotypes for histone. It appears that a 
sequence lement in the regulatory domain, the pseu- 
dosubstrate site, is of critical importance to this sub- 
strate selectivity [13]. The pseudosubstrate site has an 
amino acid sequence similar to a consensus PKC phos- 
phorylation site and is thought to interact with the sub- 
strate binding site on the catalytic domain of PKC, thus 
keeping the kinase in an inactive configuration under 
resting conditions [14-171. Upon activation by cofac- 
tors, such as Ca2’, phosphatidylserine (PS) and dia- 
cylglycerol (or phorbol ester), this interaction weakens, 
allowing substrates to compete with the pseudosub- 
strate site to gain access to the catalytic domain [13]. 
Deletion of the pseudosubstrate site from PKC-q gener- 
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ates a cofactor-independent kinase in which the restric- 
tion on histone kinase activity is no longer present [13]. 
A possible consequence of these observations is that 
the amino acid sequence of the pseudosubstrate site of 
a PKC isotype determines the choice of the substrate. 
We have investigated this possibility by replacing the 
whole or parts of the PKC-q pseudosubstrate site with 
corresponding parts of the pseudosubstrate site of 
PKC-a and testing whether the histone kinase activity 
of PKCcl could thus be conferred upon PKC-q. Some 
of the chimaeric kinases show alterations in effector 
dependence and histone kinase activity in comparison 
to wild-type PKC-v. 
2. EXPERIMENTAL 
The rat PKC-?,I expression plasmid (pKS1 -PKC-r]), the PKC-r7 pol- 
yclonal antiserum and pep-q, a synthetic peptide based on the pseu- 
dosubstrate site of PKC-rl with a serine-for-alanine substitution, have 
been described before [12]. Synthetic oligonucleotides were synthe- 
sized on an Applied Biosystems PCR-Mate [13]. PKCq pseusosub- 
strate site mutants were created by polymerase chain reaction follow- 
ing a previously described strategy [13]. A 300 bp Mscl-Mscl frag- 
ment carrying the appropriate mutation was ligated into pKS1 -PKC-r7 
expression construct. Orientation and sequence of the fragment were 
then confirmed by restriction analysis and sequencing using an ol- 
igonucleotide priming outside of the cloned fragment. PKC-r) (or 
mutant) expression plasmids were transfected into COS cells by the 
CaPO, precipitation method [12,18]. At day 3 PKC-rl (or mutant) 
protein was partially purified by extracting the cells in 1% Triton 
X-100 and t&15% ammonium sulphate fractionation of the Triton- 
soluble material. The O-158 ammonium sulphate precipitate was dis- 
solved in buffer A (20 mM Tris-Cl, pH 7.5, 2 mM EDTA, 10 mM 
benzamidine, 0.3% (v/v)p-mercaptoethanol, 0.02% Triton X-100) and 
further purified over a 1 ml HiTrap heparin-Sepharose column. Frac- 
tions were collected at 0.5 ml/min with a 2.5 min isocratic wash fol- 
lowed by a gradient of NaCl in buffer A (O-2 M in 10 min). For 
biochemical analysis, freshly isolated enzyme was used in each exper- 
iment. Routinely, 5 ~1 of enzyme was assayed for 6 min in 40 ~1 as 
described in [10,12,13]. Since PKC-r7 has been shown to be Ca”- 
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independent [12,13], all assays were performed in the absence of Ca*‘- 
ions. Pep-v (10 pg per assay) or histone III-S (Sigma, concentrations 
as indicated in the text or figure legends) were used as substrate. The 
amount of histone protein was determined as described in [19]. Incor- 
poration was assessed by Cerenkov counting. Kinetic parameters were 
fitted to the Michaelis-Menten equation using the Enzfitter pro- 
gramme. SDS-PAGE was performed as described in [20]. For Western 
analysis, proteins were transferred to nitrocellulose according to [21] 
and incubated with the PKC-rl polyclonal antiserum. Immunoblots 
were processed employing the ECL system (Amersham UK). Stand- 
ard molecular biological procedures were performed as described in 
[181. 
3. RESULTS AND DISCUSSION 
The pseudosubstrate site of PKC-q is defined as the 
region surrounding Ala16i [12,22], whilst the PKC-ol 
pseudosubstrate site is the region surrounding residue 
Ala25 [23,24]. Three PKC-q pseudosubstrate site mu- 
tants were constructed containing either the whole, the 
left or the right part of the pseudosubstrate sequence of 
PKC-a (Fig. 1A). The central alanine residue in the 
pseudosubstrate site was not altered in these studies. In 
PKC-q-La, amino acids 155-160 of PKC-11 were re- 
placed with amino acids 19-24 of PKC-a. Similarly in 
PKC-q-Ra, amino acids 162-167 of PKC-11 were re- 
placed with the amino acids 26-31 of PKC-a. In PKC- 
q-LIRa the amino acids 155-167 of PKC-r] were re- 
placed with residues 19-3 1 of PKC-cc. 
COS cells were transfected with wild-type PKC-q or 
pseudosubstrate site mutants and after 3 days they were 
extracted in standard Triton-containing extraction 
buffer [ 12,131. Fig. 1B shows that all three chimaeric 
PKC-11 proteins were readily extractable in Triton X- 
100. However, around 30% of PKC-q and PKC-q-WRa 
protein remained in the Triton-insoluble fraction, whilst 
less than 10% of PKC-v-La or wild-type PKC-q was 
Triton-insoluble (Fig. lB, lanes 1). The increase in Tri- 
A 
REGULATORY CATALYTIC 
II II I 
PKC-q TRKRQR Ale’ MRRRVH 
PKC-q-La RFARKG A16’ MRRRVH 
PKC-q-Ra TRKRQR A16’ LRQKNV 
PKC-WJRa RFARKG Alei LRQKNV 
ton-insoluble (cytoskeleton-associated) PKC+R& and 
PKC-q-LIRa correlates with the activated status of 
these mutants (see below) and suggests that the effector 
dependence observed in vitro is a reflection of their 
dependence in vivo. A similar correlation has been ob- 
served previously for activating mutants of PKC-a [24]. 
Subsequently, Triton-soluble material was fraction- 
ated by ammonium sulphate precipitation. Like wild- 
type PKC-q, the three pseudosubstrate mutants de- 
scribed in the present study precipitate in 15% ammo- 
nium sulphate (Fig. lB, lanes 2 and 3). Previously it has 
been shown that PKC-a (which is endogenously present 
in COS cells) is not present in this O-15% ammonium 
sulphate fraction [12]. Thus the ammonium sulphate 
fractionation step provides a convenient way of separat- 
ing (mutant) recombinant PKC-q from endogenous 
PKC-a and makes the protein suitable for biochemical 
analysis. 
Ammonium sulphate precipitates were further puri- 
fied by heparin-Sepharose chromatography. Each frac- 
tion was tested for its ability to phosphorylate pep-q 
(the synthetic peptide based on the pseudosubstrate site 
of PKC-q [12]) either in the presence or in the absence 
of the cofactors, PS and 12-O-tetradecanoylphorbol 13- 
acetate (TPA; Fig. 2). Like PKC-r7 itself, PKC-q-La, 
PKC+-Ra and PKC+L/R& were potent pep-q ki- 
nases. PKC-?,r and PKC-q-La were both dependent on 
PS and TPA for pep-q kinase activity. However, PKC- 
q-La showed slightly higher cofactor-independent pep- 
?,r kinase activity than the wild-type protein. By contrast 
PKC-r]-Ra and PKC-q-WRa were largely PS- and 
TPA-independent (Fig. 2). These characteristics of 
PKC-+Ra and PKC-q-L&x are similar to those ob- 
served before for a PKC-11 pseudosubstrate site deletion 
mutant and for the free catalytic domain of PKQ [ 131. 
Histone is known to be a poor substrate for PKC-);I 
Fig. 1. (A) Structure of PKC-q and PKC-rl pseudosubstrate site mutants. The variable and conserved omains in the PKC structure are indicated 
according to [7]. The amino acid sequence of the pseudosubstrate sites in each protein is expanded. (B) SDS-PAGE analysis of PKCg (WT) and 
PKC-r] pseudosubstrate site mutants. The Triton-insoluble fraction (lanes 1), 045% ammonium sulphate precipitate of the Triton-soluble fraction 
(lanes 2) and the 1545% ammonium sulphate precipitate of the Triton-soluble fraction (lanes 3) were analyzed by 10% SDS-PAGE and Western 
blotting. For details see [12]. The position of molecular weight markers (Rainbow markers, Amersham) is shown on the left (kDa). The arrowhead 
indicates the position of PKC-rl or PKC-q pseudosubstrate site mutants. The 66 kDa immunoreactive protein in the WT and La lanes is aspecific. 
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Pig. 2, Pep-v kitrate activity of PKC-q and PKC-p pseudosubstrate mutants after hepclrin-Sepharose chromatography. CQS mells were transfected 
with the indicated constructs and after 3 days PKCq or mutant protein was partially purified by extraction in 1% Triton X-IOU, O-1 5% ammonium 
sulpbate fractionation and heparin-Se&arose: chromatography. 5~1 of each fraction was tested for pep+ kinase activity in the &sence @) or in 
the presence @> of PS and TPA. Comparable restits were obtained in a second experiment using distinct enzyme preparations. 
in vitro ~a~~a~~~ rU, Xi pghd fI31). We i~~~~igated 
whether the present PKC-q chimaeric kinases differed 
from wild-type PKC-q in their ability to phosphorylase 
histone, Fig. 3 shows the histone kin&se activity of the 
pseudosubstrate site mutants in the presence of PS and 
TPA at different concentrations of histone. It appears 
that PKC-q-R& and PKC-q-WRcl ore efficient histone 
kinases in comparison with PKC-q-La;, Wistone kinase 
activity of PKC-~-RE and PKC-q-L/Ra did not depend 
on the presence of PS and TPA (Table I). The apparent 
kr, value for histone of PKC-q-h is comparable to that 
of wild-tie PKGq (50 p&ml fl3]) and 17fold higher 
than that of PKC-q-R= or PIE-q-L&x (Table I). Pre- 
viously we observed that the catalytic domain of PKC-q 
and a PIE-q pseudosubstrate site deletion mutant 
showed a similar increased (25-fold) affinity for histone 
in comparison to wild-type PKC-q [13]. V,,, values of 
PKC-rl_ La, PKC-q-Ra and PKC-rl_L/Ra are similar to 
each other (Table I>. 
The results described here indicate the importance of 
the pseudosubstrate site for substrate selectivity of 
PKC-q (see 1135). Changing the pseudosubstrate site 
alters the abihty of tlx res~ti~~ mutant to phospho- 
rylate histone by altering the apparent al&&y for the 
-I 
0 100 200 300 400 500 600 
[Histone IfIS} (uglml) 
Fig, 3. Concentration dependence of histoae phosphorylation by 
PKCq pseudosubstrate mutants. 5 jd of the peak fraction of each 
enzyme from Fig. 2 was tested for histone kin&se activity in the pres- 
ence of PS and TPA. Mean and range of duplicate incubations is 
indiitad. (A) PKC-q-La; (ZI) PKCq-Rz fo> PK.C-&!RLZ Compa- 
rabge resu&s were obt&ned in a sec+md e~~~e~t using distinct 
enzyme p~~ra~on~ 
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substrate. Thus in wild-type PKC-11 the pseudosubstrate 
site maintains the restriction on histone kinase activity 
even in the presence of PS and TPA. It is pertinent to 
note that the pseudosubstrate site mutants tested show 
both loss of substrate selectivity and enhanced cofactor- 
independent activity or do not show any change at all. 
We have not yet encountered a situation in which 
changes in substrate selectivity occur in the absence of 
changes in cofactor dependence. Therefore it is likely 
that both cofactor dependence and substrate selectivity 
are inseparable consequences of the same phenomenon, 
i.e. the interaction between the pseudosubstrate site and 
the substrate binding site on the catalytic domain (pseu- 
dosubstrate site inhibition). 
The present findings allow a description of the resi- 
dues relevant for the pseudosubstrate site inhibition 
and, by inference, of the residues interacting with the 
substrate binding site on the catalytic domain. Since 
replacing the 6 residues upstream of Ala16’ with their 
PKC-cl sequence did not affect histone kinase activity 
or cofactor dependence of PKC-r], it seems that these 
residues are not of critical importance. However, Arg158, 
which did not change in the present study because it is 
the same in PKC-a and PKC-11, could still be important 
for pseudosubstrate inhibition. It was observed before 
that this residue is important for peptides to compete 
with the pseudosubstrate site in PKC-@l&16]. Replac- 
ing the 6 residues downstream of Ala161 induces dra- 
matic changes in cofactor dependence and substrate se- 
lectivity of the kinase. Thus it appears that these resi- 
dues are of critical imporatance for the pseudosubstrate 
site inhibition in PKC-7. It is difficult to attribute the 
changes to a particular residue, however, converting 
Argr@ into Gln could be the modification mainly re- 
sponsible for the functional changes in the kinase. 
We have reported previously that pep-a (a synthetic 
peptide based on the pseudosubstrate s quence of PKC- 
a with a serine for alanine substitution) is a poor sub- 
strate of PKQ due to very low apparent affinity [12]. 
The present findings provide some explanation for this 
Table I 
K,,, and Vmax values for histone phosphorylation by PKC-r] pseudosub- 
strate mutants 
X, @g/ml) V,,, (nmol/min/ml) 
-PSlTPA +PS/TPA -PS/TPA +PSlTPA 
PKC-q-La ns 178 0.6* 1.2 
PKC-r]-Ru 13 11 1.4 1.3 
PKC-r]-L/Ra 6.8 11 1.2 1.2 
Values were calculated on the basis of Fig. 3. For comparison, the 
values previously obtained for intact PKC-q and for the PKC-q cata- 
lytic domain have been included (see [13]). ns, no saturation of the 
PKC-La mutant by histone under these conditions. 
*0.6 nmol/min/ml is the activity at 520 &ml histone. 
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observation. The characteristics of PKC-q-Ra and 
PKC-q-L/Rol indicate that residues in the pseudosub- 
strate site of PKC-a do not interact strongly with the 
PKC-r substrate binding domain. Since the sequence of 
pep-a: is in fact based on these residues, it is nor surpris- 
ing that the competitive capacity of pep-a is not strong 
enough to overcome the pseudosubstrate site inhibition 
retained in activated PKC-);I, and thus behaves as a poor 
substrate in vitro. 
In conclusion, our data indicate that the pseudosub- 
strate site of PKC-?I is of critical importance to be ob- 
served substrate selectivity of this kinase and, in partic- 
ular, they indicate the relevance of the amino acids 
downstream of Ala161. The observation that loss of sub- 
strate selectivity is always parallelled by a loss in cofac- 
tor dependence indicates that both are possibly conse- 
quences of the same phenomenon, the pseudosubstrate 
site inhibition. This is consistent with the idea that (for 
PKC) substrate phosphorylation essentially consists of 
two components. First a weakening (but not loss) of the 
interaction between pseudosubstrate site and substrate 
binding domain is induced by PS and TPA. Then sub- 
strate competes with the pseudosubstrate site for occu- 
pation of the substrate binding domain. This provides 
an attractive working hypothesis to further investigate 
substrate selectivity at the molecular level. 
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